CompletedEUCTR 2006-001471-37
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyADHDHistorical research record
- Countries
- Germany
- Sponsor
- Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen
CompletedNCT00190775
About this title
A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Read the official source — NCT00190775What is this study about?Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including IrvineADHDMedication studyAges 18+
- Countries
- United States
- Sponsor
- Eli Lilly and Company
CompletedNCT02371889
Official study titleA Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
This study has finished and is no longer accepting participants.
In PhiladelphiaAddictionMedication studyAges 18–70
- Countries
- United States
- Sponsor
- University of Pennsylvania
CompletedEUCTR 2011-005878-37
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaDepressionHistorical research record
- Countries
- Austria, Czechia, Italy, + 3 others
- Sponsor
- ANGELINI
CompletedEUCTR 2006-000846-38
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyBipolarityHistorical research record
- Countries
- Germany
- Sponsor
- Janssen-Cilag International N.V.
CompletedEUCTR 2005-005812-25
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GreeceBipolarityHistorical research record
- Countries
- Greece, Lithuania
- Sponsor
- Janssen-Cilag International N.V.
TerminatedNCT01615185
Official study titleA Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia
This study ended early.
In Kaohsiung CitySchizophreniaMedication studyAges 18–55
- Countries
- Taiwan
- Sponsor
- Kaohsiung Kai-Suan Psychiatric Hospital
CompletedEUCTR 2014-004586-24
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumDepressionHistorical research record
- Countries
- Belgium, Czechia, Germany, + 5 others
- Sponsor
- Janssen-Cilag International NV
CompletedEUCTR 2014-004588-19
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumDepressionHistorical research record
- Countries
- United Kingdom, Belgium, Bulgaria, + 5 others
- Sponsor
- Janssen-Cilag International NV
CompletedEUCTR 2022-000461-41
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaDepressionHistorical research record
- Countries
- France, Bulgaria, Czechia, + 1 other
- Sponsor
- Janssen-Cilag International NV
CompletedEUCTR 2011-001436-33
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyDepressionHistorical research record
- Countries
- Germany
- Sponsor
- F. Hoffmann-La Roche Ltd
TerminatedEUCTR 2019-003369-16
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In PolandSchizophreniaHistorical research record
- Countries
- Poland, Spain
- Sponsor
- GW Research Ltd.